India, Feb. 23 -- KKR said it will acquire a controlling stake in Indian healthcare provider Healthcare Global Enterprises for $400 million.
KKR announced the signing of definitive agreements with CVC, a global private markets manager, under which funds managed by KKR will become the largest shareholder in Healthcare Global Enterprises or HCG and assume sole control of HCG's operations.
BS Ajaikumar, Founder of Healthcare Global Enterprises, will take on the role of Non-Executive Chairman and be focused on driving clinical, academic and research and development excellence.
As part of the transaction, KKR will acquire up to 54% of equity in HCG from CVC Asia V at a purchase price of INR 445 per share. Pursuant to the Securities and Exchan...